Sorry for interrupting, this website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Learn more
Accept & Close

Gastrointestinal Remedies - US - April 2012

Sales of gastrointestinal (GI) remedies grew considerably in 2009, in part because of strong demand for over-the-counter (OTC) versions of prescription remedies such as Prilosec OTC. This growth, however, decelerated in 2010 and 2011. While significant opportunities exist in the category, it is evident that at this point in history brands must work harder than ever to garner customer loyalty and differentiate if they want to succeed in this challenging marketplace. This is especially true for national brands, as they have been losing share to private label in recent years.

In order to provide facts and insights that can help companies succeed in this challenging marketplace, Mintel has published this report which addresses the following questions:

  • How have sales of antacids, laxatives, stomach remedies and diarrheal remedies fluctuated in recent years and how are they likely to change in the future?
  • How are macro-level economic and health-related factors driving sales of GI remedies?
  • What are the leading brands in the category and how are they performing in comparison to private label?
  • How widespread are GI problems in the U.S. and what types of conditions are most common?
  • What types of strategies are used most often by Americans to manage GI health?
  • What types of remedies are most popular with Americans and what brands are they most likely to use?
  • How do various factors, such as recommendations from a friend or coworker, impact brand decisions?

What you get

What's included

Why buy from us?

Succeed

Our reports will provide you with market data, consumer research and competitive intelligence to succeed in your market.

Instant Access

Buy now and you'll have instant access to the information you need to make the right decisions.

Opportunities

Find out what's next in the markets that matter to you: where opportunities lie and what challenges you will face.

Trusted

A business Superbrand, Mintel is a source you can trust. We have been defining and refining the Market Intelligence mix since 1972.

Table of contents

  1. Scope and Themes

    • What you need to know
      • Definition
        • Data sources
          • Sales data
            • Consumer survey data
              • Advertising creative
                • Abbreviations and terms
                  • Abbreviations
                    • Terms
                    • Executive Summary

                        • Market factors
                          • Figure 1: Preferences in managing digestive health, by age, December 2011
                        • Obesity trend drives demand
                          • Sales unlikely to change substantially between 2012 and 2016
                            • Figure 2: Total U.S. sales and fan chart forecast of gastrointestinal remedies, at current prices, 2006-16
                          • Antacids remain dominant category
                            • Figure 3: Sales of gastrointestinal remedies, segmented by type, 2009 and 2011
                          • Understanding the consumer
                            • Gas, upset stomach, diarrhea, heartburn, and constipation common ailments
                              • Figure 4: Gastrointestinal problems experienced, December 2011
                            • Several factors more important than price
                              • Figure 5: Summary of importance of product attributes to GI remedy selection, December 2011
                            • What we think
                            • Insights and Opportunities

                              • Introduce more “natural” remedies to drive growth
                                  • Figure 6: Importance of product attributes to selection, by those who ranked natural ingredients as very important, December 2011
                                • Consider developing “mini-packs” to drive sales of national brands
                                  • Blogs and networking sites can help brands as well as consumers
                                    • Figure 7: Important components of OTC product selection, by those who rate blogs or social networking sites as important, December 2011
                                • Inspire Insights

                                    • Trend: Perfecting the Details
                                      • Trend: Mood to Order
                                      • Market Size and Forecast

                                        • Key points
                                          • Sales fall in 2011 along with declines in branded PPIs
                                            • Figure 8: Total U.S. retail sales and forecast of gastrointestinal remedies, at current prices, 2006-16
                                            • Figure 9: Total U.S. retail sales and forecast of gastrointestinal remedies, at inflation-adjusted prices, 2006-16
                                          • Fan chart forecast
                                              • Figure 10: Total U.S. sales and fan chart forecast of gastrointestinal remedies, at current prices, 2006-16
                                            • Walmart sales
                                            • Market Drivers

                                              • Key points
                                                • Some make food choices knowing they will require GI remedies
                                                  • Figure 11: Summary of preferences in managing digestive health, December 2011
                                                • Many suffer from GI issues
                                                  • Figure 12: Ailments experienced in past 12 months by age, April 2010-June 2011
                                                • Population growth will drive long-term sales
                                                  • Figure 13: Population by age, 2006-16
                                                  • Figure 14: Consulting a gastroenterologist by age, July 2010-September 2011
                                                • Obesity trend drives demand for remedies
                                                  • Figure 15: Incidence of being overweight or obese in the U.S. among adults aged 18+, 2005-10
                                                • Most rate themselves as having good digestive health
                                                  • Figure 16: Digestive health rating, by gender and age, November 2011
                                                • Improving economy could help drive growth in 2012
                                                  • Figure 17: Unemployment trends, 2007-12
                                                  • Figure 18: Consumer confidence, 2007-12
                                              • Competitive Context

                                                • Many address GI issues proactively with diet, avoiding need for remedies
                                                  • Figure 19: Managing digestive health, by gender, November 2011
                                              • Segment Performance

                                                • Key points
                                                  • Declines in antacids, stomach remedies, and antidiarrheals
                                                    • Figure 20: Total U.S. sales of gastrointestinal remedies, segmented by type, 2009 and 2011
                                                • Segment Performance—Antacids

                                                  • Key points
                                                    • Growth slows with rise in private label and decline in introductions
                                                      • Figure 21: Sales and forecast of antacids, at current prices, 2006-16
                                                  • Segment Performance—Laxatives

                                                    • Key points
                                                      • Laxatives get boost from fiber supplements and Fleet products
                                                        • Figure 22: Sales and forecast of laxatives, at current prices, 2006-16
                                                    • Segment Performance—Stomach Remedies

                                                      • Key points
                                                        • Sales of remedies down as consumers turn to inexpensive private label options
                                                          • Figure 23: Sales and forecast of stomach remedies, at current prices, 2006-16
                                                      • Segment Performance—Antidiarrheals

                                                        • Key points
                                                          • Sales and forecast of antidiarrheals
                                                            • Figure 24: Sales and forecast of antidiarrheals, at current prices, 2006-16
                                                        • Retail Channels

                                                          • Drug and mass are the key channels
                                                            • Figure 25: Sales of gastrointestinal remedies, by channel, 2009 and 2011
                                                        • Retail Channels—Drug Stores

                                                          • Key points
                                                            • Drug store sales play a key role in driving category growth
                                                                • Figure 26: Drug store sales of gastrointestinal remedies, at current prices, 2006-11
                                                            • Retail Channels—Supermarkets

                                                              • Key points
                                                                • Supermarkets continue to lag behind dominant channels
                                                                  • Figure 27: Supermarket sales of gastrointestinal remedies, at current prices, 2006-11
                                                              • Retail Channels—Other

                                                                • Key points
                                                                  • “Other” posts some growth with supercenters and private label
                                                                    • Figure 28: “Other” sales of gastrointestinal remedies, at current prices, 2006-11
                                                                • The Natural Channel Marketplace

                                                                  • Key points
                                                                    • Probiotic supplements support strong growth
                                                                      • Sales of gastrointestinal remedies in the natural channel
                                                                        • Figure 29: Natural supermarket sales of gastrointestinal remedies at current prices, 2009-11
                                                                        • Figure 30: Natural supermarket sales of gastrointestinal remedies, at inflation-adjusted prices, 2009-11
                                                                      • Natural channel sales by segment
                                                                        • Figure 31: Natural supermarket sales of GI remedies, by segment, 2009-11
                                                                      • Brands of significance
                                                                      • Leading Companies

                                                                        • Key points
                                                                          • Manufacturer sales of gastrointestinal remedies
                                                                            • Private label increasingly dominant force in the category
                                                                              • Figure 32: Manufacturer sales of gastrointestinal remedies, 2010 and 2011
                                                                          • Brand Share—Antacids

                                                                            • Key points
                                                                              • Prilosec OTC remains dominant national brand but losing ground
                                                                                • Tums drives significant growth for GlaxoSmithKline
                                                                                  • Zantac packaging redesign suggests growth could continue
                                                                                    • Private label continues to drive category growth
                                                                                        • Figure 33: FDMx manufacturer sales of antacids, 2010 and 2011
                                                                                    • Brand Share—Laxatives

                                                                                      • Key points
                                                                                        • Metamucil gains ground with “MultiHealth” positioning
                                                                                          • Dulcolax gains ground on heels of innovative campaign
                                                                                            • Fleet continues growth with differentiated offering
                                                                                              • Private label packaging could invite brand confusion
                                                                                                • Figure 34: FDMx manufacturer sales of laxatives, 2010 and 2011
                                                                                            • Brand Share—Stomach Remedies

                                                                                              • Key points
                                                                                                • Pepto-Bismol still dominant but losing ground to private label
                                                                                                  • Phillips another target of retailers’ packaging strategy
                                                                                                    • Figure 35: FDMx manufacturer sales of stomach remedies, 2010 and 2011
                                                                                                • Brand Share—Antidiarrheals

                                                                                                  • Key points
                                                                                                    • Imodium continues losing ground
                                                                                                      • Private label sales continue rapid growth
                                                                                                        • Figure 36: FDMx manufacturer sales of antidiarrheals, 2010 and 2011
                                                                                                    • Innovations and Innovators

                                                                                                      • Total number of new product introductions fell sharply in 2011
                                                                                                        • Figure 37: Tops 10 claims associated with new GI launches, 2006-January 2012
                                                                                                      • Most new introductions come from national brands
                                                                                                        • Figure 38: Branded vs. private label launches, 2006-January 2012
                                                                                                      • Layered soft gels contribute to efficacy of probiotics
                                                                                                        • Remedies for pregnant women could drive growth
                                                                                                          • Natural could be the next big thing
                                                                                                          • Marketing Strategies

                                                                                                            • Overview of the brand landscape
                                                                                                              • Pepto-Bismol
                                                                                                                • Figure 39: Brand analysis of Pepto-Bismol, 2012
                                                                                                              • Television advertising
                                                                                                                • Figure 40: Pepto-Bismol television ad, 2012
                                                                                                                • Figure 41: Pepto-Bismol television ad, 2011
                                                                                                              • Website
                                                                                                                • Figure 42: Pepto-Bismol website, 2012
                                                                                                              • Facebook
                                                                                                                • Figure 43: Pepto-Bismol Facebook account, 2012
                                                                                                              • Tums
                                                                                                                • Figure 44: Brand analysis of Tums, 2012
                                                                                                              • Television advertising
                                                                                                                • Figure 45: Tums television ad, 2012
                                                                                                                • Figure 46: Tums Fresheners television ad, 2012
                                                                                                              • Website
                                                                                                                • Figure 47: Tums website, 2012
                                                                                                              • Facebook
                                                                                                                • Figure 48: Tums Facebook account, 2012
                                                                                                              • Prilosec OTC
                                                                                                                • Figure 49: Brand analysis of Prilosec OTC, 2012
                                                                                                              • Television advertising
                                                                                                                • Figure 50: Prilosec OTC ad, 2012
                                                                                                                • Figure 51: Prilosec OTC ad, 2011
                                                                                                              • Website
                                                                                                                • Figure 52: Prilosec OTC website, 2012
                                                                                                            • Gastrointestinal Problems

                                                                                                              • Key points
                                                                                                                • Most experience GI problems once per month or less
                                                                                                                  • Figure 53: Gastrointestinal problems experienced, December 2011
                                                                                                                • Women are a key target for marketers of GI remedies
                                                                                                                  • Figure 54: Summary of gastrointestinal problems experienced, by gender, December 2011
                                                                                                                • Few differences between ages in incidence of minor ailments
                                                                                                                  • Figure 55: Summary of gastrointestinal problems experienced, by age, December 2011
                                                                                                              • Managing Digestive Health

                                                                                                                • Key points
                                                                                                                  • Most would prefer to manage digestive health through diet alone
                                                                                                                    • Figure 56: Summary of preferences in managing digestive health, December 2011
                                                                                                                  • Young adults more likely to have interest in fortified food and drink
                                                                                                                    • Figure 57: Preferences in managing digestive health, by age, December 2011
                                                                                                                • Remedy Types Used

                                                                                                                  • Key points
                                                                                                                    • Antacids most commonly used remedy
                                                                                                                      • Figure 58: OTC remedies used to ease digestive issues, by gender, December 2011
                                                                                                                    • 35-64s key segment for antacid manufacturers
                                                                                                                      • Figure 59: OTC remedies used to ease digestive issues, by age, December 2011
                                                                                                                    • Affluents more likely to use antacids, fiber supplements and probiotics
                                                                                                                      • Figure 60: OTC remedies used to ease digestive issues, by household income, December 2011
                                                                                                                  • Heartburn/Indigestion Aids

                                                                                                                    • Key points
                                                                                                                      • Most users rely on antacids two to three times per month or more
                                                                                                                        • Figure 61: Number of times used heartburn/indigestion aids in past six months, July 2010-September 2011
                                                                                                                      • Tums growth driven by strong demand for chewable tablets
                                                                                                                        • Figure 62: Type of heartburn/indigestion aids used, by gender, July 2010-September 2011
                                                                                                                      • Affluents also more likely to use chewable tablets
                                                                                                                        • Figure 63: Type of heartburn/indigestion aids used, by household income, July 2010-September 2011
                                                                                                                      • Fruit flavor most popular
                                                                                                                        • Figure 64: Kinds of heartburn/indigestion aids used, by age, July 2010-September 2011
                                                                                                                    • Laxatives

                                                                                                                      • Key points
                                                                                                                        • Most women prefer tablets
                                                                                                                          • Figure 65: Type of laxatives used, by gender, July 2010-September 2011
                                                                                                                        • Most users consume laxatives once per month or less
                                                                                                                          • Figure 66: Number of times used laxatives in past six months, by gender, July 2010-September 2011
                                                                                                                      • Product Selection

                                                                                                                        • Key points
                                                                                                                          • Doctor and pharmacist recommendations tend to be most influential
                                                                                                                            • Figure 67: Summary of important components in OTC product selection, December 2011
                                                                                                                          • Most women influenced by social networks and package messaging
                                                                                                                            • Figure 68: Important components of OTC product selection, by gender, December 2011
                                                                                                                          • Target young adults with online and viral campaigns
                                                                                                                            • Figure 69: Important components of OTC product selection, by age, December 2011
                                                                                                                        • Importance of Product Attributes

                                                                                                                          • Key points
                                                                                                                            • Fast acting, lack of side effects, and ease of use all critical attributes
                                                                                                                              • Figure 70: Summary of importance of product attributes to selection, December 2011
                                                                                                                            • Most attributes more important to women than men
                                                                                                                              • Figure 71: Importance of product attributes to selection, by gender, December 2011
                                                                                                                            • Price, added benefits, and friends more likely to influence young adults
                                                                                                                              • Figure 72: Importance of product attributes to selection, by age, December 2011
                                                                                                                            • Most attributes more likely to influence low-income users
                                                                                                                              • Figure 73: Importance of product attributes to selection, by household income, December 2011
                                                                                                                          • Brand Selection

                                                                                                                            • Key points
                                                                                                                              • Women less likely to be brand loyal
                                                                                                                                • Figure 74: Gastrointestinal remedy brand selection, by gender, December 2011
                                                                                                                              • Mature adults often report being brand loyal
                                                                                                                                • Figure 75: Gastrointestinal remedy brand selection, by age, December 2011
                                                                                                                              • Tums and Pepto-Bismol particularly popular with young adults
                                                                                                                                • Figure 76: Brands of heartburn/indigestion aids used, by age, July 2010-September 2011
                                                                                                                            • Attitudes and Concerns

                                                                                                                              • Key points
                                                                                                                                • Most only use remedies when they are really needed
                                                                                                                                  • Figure 77: Summary of attitudes toward and concerns about gastrointestinal remedies, December 2011
                                                                                                                                • Women more likely to only use when necessary
                                                                                                                                  • Figure 78: Attitudes toward and concerns about gastrointestinal remedies, by gender, December 2011
                                                                                                                              • Likelihood of Trying

                                                                                                                                • Key points
                                                                                                                                  • Maximum strength formulations can drive brand adoption among nonusers
                                                                                                                                    • Figure 79: Summary of likelihood of trying gastrointestinal remedies that promote listed benefits, December 2011
                                                                                                                                  • 35-54s motivated to experiment by a range of attributes
                                                                                                                                    • Figure 80: Likelihood of trying gastrointestinal remedies that promote listed benefits, by age, December 2011
                                                                                                                                • Race and Hispanic Origin

                                                                                                                                  • Key points
                                                                                                                                    • Blacks and Hispanics more likely to report interest in fortified food and beverage
                                                                                                                                      • Figure 81: Preferences in managing digestive health, by race/Hispanic origin, December 2011
                                                                                                                                    • Blacks more likely to use laxatives
                                                                                                                                      • Figure 82: OTC remedies used to ease digestive issues, by race/Hispanic origin, December 2011
                                                                                                                                    • Blacks and Hispanics more likely to be influenced by ads and sites
                                                                                                                                      • Figure 83: Important components of OTC product selection, by race/Hispanic origin, December 2011
                                                                                                                                    • Blacks and Hispanics can be targeted with new products
                                                                                                                                      • Figure 84: Likelihood of trying gastrointestinal remedies that promote listed benefits, by race/Hispanic origin, December 2011
                                                                                                                                    • Blacks and Hispanics are more likely to express some concerns
                                                                                                                                      • Figure 85: Attitudes toward and concerns about gastrointestinal remedies, by race/Hispanic origin, December 2011
                                                                                                                                  • Cluster Analysis

                                                                                                                                      • The Indulgent
                                                                                                                                        • Demographics
                                                                                                                                          • Characteristics
                                                                                                                                            • Opportunity
                                                                                                                                              • Minimal Needs
                                                                                                                                                • Demographics
                                                                                                                                                  • Characteristics
                                                                                                                                                    • Opportunity
                                                                                                                                                      • Doubters
                                                                                                                                                        • Demographics
                                                                                                                                                          • Characteristics
                                                                                                                                                            • Opportunity
                                                                                                                                                              • Cluster characteristic tables
                                                                                                                                                                • Figure 86: Gastrointestinal problems experienced, by target groups, December 2011
                                                                                                                                                                • Figure 87: Preferences in managing digestive health, by target groups, December 2011
                                                                                                                                                                • Figure 88: OTC remedies used to ease digestive issues, by target groups, December 2011
                                                                                                                                                                • Figure 89: Important components of OTC product selection, by target groups, December 2011
                                                                                                                                                                • Figure 90: Gastrointestinal remedy brand selection, by target groups, December 2011
                                                                                                                                                                • Figure 91: Importance of product attributes to selection, by target groups, December 2011
                                                                                                                                                                • Figure 92: Attitudes toward and concerns about gastrointestinal remedies, by target groups, December 2011
                                                                                                                                                                • Figure 93: Likelihood of trying GI remedies that promote listed benefits, by target groups, December 2011
                                                                                                                                                              • Cluster demographics
                                                                                                                                                                • Figure 94: Target group demographic profile, December 2011
                                                                                                                                                              • Cluster methodology
                                                                                                                                                              • Custom Consumer Groups

                                                                                                                                                                • Most respondents in all custom groups experience some GI issues
                                                                                                                                                                  • Figure 95: Gastrointestinal problems experienced, by gender and age, December 2011
                                                                                                                                                                • Laxative marketers can benefit by targeting women aged 35-54
                                                                                                                                                                  • Figure 96: OTC remedies used to ease digestive issues, by gender and age, December 2011
                                                                                                                                                                • Target young adults and middle-aged women with viral campaigns
                                                                                                                                                                    • Figure 97: Important components of OTC product selection, by gender and age, December 2011
                                                                                                                                                                  • Mature women most likely to cite key attributes as very important
                                                                                                                                                                      • Figure 98: Importance of product attributes to selection, by gender and age, December 2011
                                                                                                                                                                    • Mature men most likely to be brand loyal
                                                                                                                                                                      • Figure 99: Gastrointestinal remedy brand selection, by gender and age, December 2011
                                                                                                                                                                  • SymphonyIRI Group Builders Panel Data—Key Household Purchase Measures

                                                                                                                                                                      • Overview
                                                                                                                                                                        • Gastrointestinal tablets
                                                                                                                                                                          • Gastrointestinal liquids
                                                                                                                                                                            • Antacid tablets
                                                                                                                                                                              • Consumer insights on key purchase measures
                                                                                                                                                                                • Brand map
                                                                                                                                                                                  • Figure 100: Brand map, selected brands of antacid tablets, by household penetration, 52 weeks ending 6/26/2011
                                                                                                                                                                                • Brand leader characteristics
                                                                                                                                                                                  • Key purchase measures
                                                                                                                                                                                    • Figure 101: Key purchase measures for the top brands of antacid tablets, by household penetration, 52 weeks ending 6/26/2011
                                                                                                                                                                                  • Antacid liquid/powder
                                                                                                                                                                                    • Consumer insights on key purchase measures
                                                                                                                                                                                      • Brand map
                                                                                                                                                                                        • Figure 102: Brand map, selected brands of antacid liquid/powder buying rate, by household penetration, 52 weeks ending 6/26/2011
                                                                                                                                                                                      • Brand leader characteristics
                                                                                                                                                                                        • Key purchase measures
                                                                                                                                                                                          • Figure 103: Key purchase measures for the top brands of antacid liquid/powder, by household penetration, 52 weeks ending 6/26/2011
                                                                                                                                                                                        • Laxative tablets
                                                                                                                                                                                          • Consumer insights on key purchase measures
                                                                                                                                                                                            • Brand map
                                                                                                                                                                                              • Figure 104: Brand map, selected brands of laxative tablets, by household penetration, 52 weeks ending 6/26/2011
                                                                                                                                                                                            • Brand leader characteristics
                                                                                                                                                                                              • Key purchase measures
                                                                                                                                                                                                • Figure 105: Key purchase measures for the top brands of laxative tablets, 52 weeks ending 6/26/2011
                                                                                                                                                                                              • Laxative/stimulant liquid/powder/oil
                                                                                                                                                                                                • Consumer insights on key purchase measures
                                                                                                                                                                                                  • Brand map
                                                                                                                                                                                                    • Figure 106: Brand map, selected brands of laxative/stimulant liquid/powder/oil buying rate, by household penetration, 52 weeks ending 6/26/2011
                                                                                                                                                                                                  • Brand leader characteristics
                                                                                                                                                                                                    • Key purchase measures
                                                                                                                                                                                                      • Figure 107: Key purchase measures for the top brands of laxative/stimulant liquid/powder/oil, by household penetration, 52 weeks ending 6/26/2011
                                                                                                                                                                                                    • Stomach remedy liquid/powder
                                                                                                                                                                                                      • Consumer insights on key purchase measures
                                                                                                                                                                                                        • Brand map
                                                                                                                                                                                                          • Figure 108: Brand map, selected brands of stomach remedy liquid/powder buying rate, by household penetration, 52 weeks ending 6/26/2011
                                                                                                                                                                                                        • Brand leader characteristics
                                                                                                                                                                                                          • Key purchase measures
                                                                                                                                                                                                            • Figure 109: Key purchase measures for the top brands of stomach remedy liquid/powder, by household penetration, 52 weeks ending 6/26/2011
                                                                                                                                                                                                        • Appendix: Other Useful Consumer Tables

                                                                                                                                                                                                            • Figure 110: Preferences in managing digestive health, by gender, December 2011
                                                                                                                                                                                                            • Figure 111: Preferences in managing digestive health, by gender and age group, December 2011
                                                                                                                                                                                                            • Figure 112: Important components of OTC product selection, by household income, December 2011
                                                                                                                                                                                                            • Figure 113: Importance of product attributes to selection, by those who rate various personal sources important, December 2011
                                                                                                                                                                                                            • Figure 114: Importance of product attributes to selection, by those who rate various other sources important, December 2011
                                                                                                                                                                                                            • Figure 115: Gastrointestinal remedy brand selection, by household income, December 2011
                                                                                                                                                                                                            • Figure 116: Gastrointestinal remedy brand selection, by race/Hispanic origin, December 2011
                                                                                                                                                                                                            • Figure 117: Attitudes toward and concerns about gastrointestinal remedies, by age, December 2011
                                                                                                                                                                                                            • Figure 118: Attitudes toward and concerns about gastrointestinal remedies, by household income, December 2011
                                                                                                                                                                                                            • Figure 119: Attitudes toward and concerns about gastrointestinal remedies, by gender and age, December 2011
                                                                                                                                                                                                            • Figure 120: Likelihood of trying gastrointestinal remedies that promote listed benefits, by gender, December 2011
                                                                                                                                                                                                            • Figure 121: Likelihood of trying gastrointestinal remedies that promote listed benefits by gender and age, December 2011
                                                                                                                                                                                                            • Figure 122: Likelihood of trying gastrointestinal remedies that promote listed benefits, by household income, December 2011
                                                                                                                                                                                                            • Figure 123: Importance of product attributes to selection, by race/Hispanic origin, December 2011
                                                                                                                                                                                                        • Appendix—SymphonyIRI Builders Panel Data Definitions

                                                                                                                                                                                                            • SymphonyIRI Consumer Network Metrics
                                                                                                                                                                                                            • Appendix: Trade Associations

                                                                                                                                                                                                              Companies Covered

                                                                                                                                                                                                              • ABC, Inc.
                                                                                                                                                                                                              • Albertsons Inc.
                                                                                                                                                                                                              • American College of Gastroenterology (ACG)
                                                                                                                                                                                                              • American Gastroenterological Association (AGA)
                                                                                                                                                                                                              • American Pharmacists Association (APhA)
                                                                                                                                                                                                              • Bayer AG
                                                                                                                                                                                                              • Boehringer Ingelheim Pharmaceuticals, Inc.
                                                                                                                                                                                                              • Centers for Disease Control and Prevention
                                                                                                                                                                                                              • Consumer Healthcare Products Association (CHPA)
                                                                                                                                                                                                              • CVS Caremark Corporation
                                                                                                                                                                                                              • Facebook, Inc.
                                                                                                                                                                                                              • Family Dollar Stores, Inc
                                                                                                                                                                                                              • Garden of Life, Inc.
                                                                                                                                                                                                              • GlaxoSmithKline (USA)
                                                                                                                                                                                                              • Johnson & Johnson
                                                                                                                                                                                                              • McNeil Consumer & Specialty Pharmaceuticals
                                                                                                                                                                                                              • Merck & Co. Inc.
                                                                                                                                                                                                              • National Broadcasting Company, Inc. (NBC)
                                                                                                                                                                                                              • Novartis AG
                                                                                                                                                                                                              • Procter & Gamble Company (The)
                                                                                                                                                                                                              • Procter & Gamble USA
                                                                                                                                                                                                              • Purdue Pharma L.P.
                                                                                                                                                                                                              • Rite Aid Corporation
                                                                                                                                                                                                              • Schering-Plough Corporation
                                                                                                                                                                                                              • Target Corporation
                                                                                                                                                                                                              • The New York Times Company
                                                                                                                                                                                                              • Twitter, Inc.
                                                                                                                                                                                                              • U.S. Bureau of Labor Statistics
                                                                                                                                                                                                              • U.S. Bureau of the Census
                                                                                                                                                                                                              • University of Michigan, The
                                                                                                                                                                                                              • US Department of Commerce
                                                                                                                                                                                                              • Walgreen Co
                                                                                                                                                                                                              • Walmart Stores (USA)
                                                                                                                                                                                                              • Whole Foods Market Inc

                                                                                                                                                                                                              Gastrointestinal Remedies - US - April 2012

                                                                                                                                                                                                              £3,199.84 (Excl.Tax)